These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30241478)

  • 21. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
    Andersen OM; Petersen HH; Jacobsen C; Moestrup SK; Etzerodt M; Andreasen PA; Thøgersen HC
    Biochem J; 2001 Jul; 357(Pt 1):289-96. PubMed ID: 11415462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model.
    Kobayashi H; Gotoh J; Fujie M; Shinohara H; Moniwa N; Terao T
    Int J Cancer; 1994 Jun; 57(5):727-33. PubMed ID: 8194882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
    J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
    Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC
    Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
    Fazioli F; Blasi F
    Trends Pharmacol Sci; 1994 Jan; 15(1):25-9. PubMed ID: 8140655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.
    Franco P; Iaccarino C; Chiaradonna F; Brandazza A; Iavarone C; Mastronicola MR; Nolli ML; Stoppelli MP
    J Cell Biol; 1997 May; 137(3):779-91. PubMed ID: 9151681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
    Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
    Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
    Mignatti P; Mazzieri R; Rifkin DB
    J Cell Biol; 1991 Jun; 113(5):1193-201. PubMed ID: 1645739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer?
    van Dam PA; Coelho A; Rolfo C
    Eur J Surg Oncol; 2017 Feb; 43(2):252-257. PubMed ID: 27345498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of tumor growth and metastasis by ATF-Fc, an engineered antibody targeting urokinase receptor.
    Hu XW; Duan HF; Gao LH; Pan SY; Li YM; Xi Y; Zhao SR; Yin L; Li JF; Chen HP; Wu CT
    Cancer Biol Ther; 2008 May; 7(5):651-9. PubMed ID: 18245952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
    Reinartz J; Link J; Todd RF; Kramer MD
    Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.
    Endo-Munoz L; Cai N; Cumming A; Macklin R; Merida de Long L; Topkas E; Mukhopadhyay P; Hill M; Saunders NA
    PLoS One; 2015; 10(8):e0133592. PubMed ID: 26317203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells.
    Bhat GJ; Gunaje JJ; Idell S
    Am J Physiol; 1999 Aug; 277(2):L301-9. PubMed ID: 10444524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of amino-acid mutations on specific interactions between urokinase-type plasminogen activator and its receptor: Ab initio molecular orbital calculations.
    Tsuji S; Kasumi T; Nagase K; Yoshikawa E; Kobayashi H; Kurita N
    J Mol Graph Model; 2011 Aug; 29(8):975-84. PubMed ID: 21605990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
    Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
    Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions.
    Wang XQ; Sun P; Paller AS
    J Invest Dermatol; 2005 Apr; 124(4):839-48. PubMed ID: 15816844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
    Ossowski L; Clunie G; Masucci MT; Blasi F
    J Cell Biol; 1991 Nov; 115(4):1107-12. PubMed ID: 1659573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
    Ando Y; Jensen PJ
    J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.